ArticlePharmaceuticals (Basel, Switzerland)2024

Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis.

Elena Campione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.